Clinical trial
An Open-label, Multicenter Trial to Assess the Safety and Tolerability of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT05061719 is registered in ClinicalTrials.gov with Intra-Cellular Therapies, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Multicenter Trial to Assess the Safety and Tolerability of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Lead sponsor
- Intra-Cellular Therapies, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 8, 2021
- Completion date
- October 23, 2024
- Enrollment
- 812 (actual)
- Sites
- 109
Conditions
As the registry lists them; a condition with its own page is linked.